Development of cattle TB vaccines in the UK

Martin Vordermeier*, R. Glyn Hewinson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (SciVal)


In 1996, an independent scientific committee chaired by Professor John Krebs, tasked to review the problem of bovine tuberculosis (TB) in GB, concluded that vaccination of cattle offered the best long-term solution for controlling the disease in the National Herd. This view has been re-affirmed recently in the House of Commons Environment, Food and Rural Affairs Committee's report on Bovine TB (2004) and by the findings of the Independent Scientific Group Vaccine Scoping Sub-committee. Significant progress in developing TB vaccines for cattle has been made over the last 5 years. Specifically: (i) DNA or protein subunit vaccines used in combination with BCG have been shown to give superior protection against experimental challenge in cattle than BCG (heterologous prime-boost); (ii) prototype reagents that allow discrimination between vaccinated and infected animals have been developed; and (iii) and correlates of disease severity have been identified that can predict the success or failure of vaccination. These significant advances are detailed in this review with a summary of future directions that TB vaccine development for cattle is likely to take. Crown

Original languageEnglish
Pages (from-to)38-48
Number of pages11
JournalVeterinary Immunology and Immunopathology
Issue number1-2
Early online date08 May 2006
Publication statusPublished - 15 Jul 2006


  • Bovine tuberculosis
  • Cattle heterologous prime-boost vaccination
  • Differential diagnosis


Dive into the research topics of 'Development of cattle TB vaccines in the UK'. Together they form a unique fingerprint.

Cite this